1. Home
  2. SXTP vs LCFY Comparison

SXTP vs LCFY Comparison

Compare SXTP & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SXTP
  • LCFY
  • Stock Information
  • Founded
  • SXTP 2010
  • LCFY 2009
  • Country
  • SXTP United States
  • LCFY Australia
  • Employees
  • SXTP N/A
  • LCFY N/A
  • Industry
  • SXTP Biotechnology: Pharmaceutical Preparations
  • LCFY
  • Sector
  • SXTP Health Care
  • LCFY
  • Exchange
  • SXTP Nasdaq
  • LCFY Nasdaq
  • Market Cap
  • SXTP 3.7M
  • LCFY 3.7M
  • IPO Year
  • SXTP 2023
  • LCFY 2022
  • Fundamental
  • Price
  • SXTP $2.34
  • LCFY $5.42
  • Analyst Decision
  • SXTP Buy
  • LCFY
  • Analyst Count
  • SXTP 2
  • LCFY 0
  • Target Price
  • SXTP $7.00
  • LCFY N/A
  • AVG Volume (30 Days)
  • SXTP 118.8K
  • LCFY 4.9M
  • Earning Date
  • SXTP 08-13-2025
  • LCFY 07-07-2025
  • Dividend Yield
  • SXTP N/A
  • LCFY N/A
  • EPS Growth
  • SXTP N/A
  • LCFY N/A
  • EPS
  • SXTP N/A
  • LCFY N/A
  • Revenue
  • SXTP $802,323.00
  • LCFY $2,668,385.00
  • Revenue This Year
  • SXTP $95.50
  • LCFY N/A
  • Revenue Next Year
  • SXTP $80.78
  • LCFY N/A
  • P/E Ratio
  • SXTP N/A
  • LCFY N/A
  • Revenue Growth
  • SXTP 118.37
  • LCFY N/A
  • 52 Week Low
  • SXTP $1.41
  • LCFY $2.28
  • 52 Week High
  • SXTP $35.99
  • LCFY $13.98
  • Technical
  • Relative Strength Index (RSI)
  • SXTP 49.40
  • LCFY 55.67
  • Support Level
  • SXTP $2.31
  • LCFY $5.16
  • Resistance Level
  • SXTP $2.49
  • LCFY $13.98
  • Average True Range (ATR)
  • SXTP 0.18
  • LCFY 1.03
  • MACD
  • SXTP 0.01
  • LCFY 0.35
  • Stochastic Oscillator
  • SXTP 75.24
  • LCFY 23.53

About SXTP 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.

About LCFY Locafy Limited

Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.

Share on Social Networks: